Bavarian aims for universal Covid-19 booster
Bavarian Nordic is betting on its vaccine candidate providing broad protection, and imminent trial results could indicate where the booster has potential.
by marketwire, translated by daniel pedersen
In February, Bavarian Nordic will have the next round of results ready from a trial of its Covid-19 vaccine candidate. According to the company’s CEO, Paul Chaplin, the vaccine will be universal in its protection, as reported by Danish business daily Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian's biggest competitors have a landmark 2022 ahead
For subscribers
